-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
THC Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2011 to 2023.
- THC Therapeutics, Inc. Revenues for the quarter ending April 30, 2024 was $0.000.
- THC Therapeutics, Inc. Revenues for the twelve months ending April 30, 2024 was $0.000.
- THC Therapeutics, Inc. annual Revenues for 2023 was $0.000.
- THC Therapeutics, Inc. annual Revenues for 2022 was $0.000.
- THC Therapeutics, Inc. annual Revenues for 2021 was $0.000.